Leveraging investments in Ebola preparedness for COVID-19 in Sub-Saharan Africa
Open Access
- 18 March 2020
- journal article
- Published by F1000 Research Ltd in AAS Open Research
Abstract
The emergence of SARS-CoV-2 in China and transmission to more than 80 territories worldwide, including nine countries in Africa, presents a delicate situation for low-resource settings. Countries in Eastern and Central Africa have been on high alert since mid-2018 in anticipation of regional spread of the Ebola virus from the Democratic Republic of Congo. Significant investment has been made to support enhanced surveillance at point of entry and hospitals, infection control practices, clinical case management, and clinical research. With a new threat on the horizon, African countries have an opportunity to leverage the existing capacities for Ebola preparedness to brace for the imminent threat.Keywords
Funding Information
- European and Developing Countries Clinical Trials Partnership (RIA2018EF-083)
- African Academy of Sciences (GCA/AMR/md2/175)
This publication has 3 references indexed in Scilit:
- A Randomized, Controlled Trial of Ebola Virus Disease TherapeuticsThe New England Journal of Medicine, 2019
- Evaluation of Infection Prevention and Control Readiness at Frontline Health Care Facilities in High-Risk Districts Bordering Ebola Virus Disease–Affected Areas in the Democratic Republic of the Congo — Uganda, 2018Morbidity and Mortality Weekly Report (MMWR), 2019
- Transition Planning For After Polio EradicationThe Journal of Infectious Diseases, 2017